Sterile Vials Market

Sterile Vials Market Outlook (2021-2031)

The global sterile vials market is quite progressive in nature, and is anticipated to ascend at around 8.5% CAGR, topping a valuation of US$ 10 billion by 2031. As the requirement for various type of sterile vials such as sterile empty vials, sterile saline-filled vials, sterile media-filled vials, and others is growing steadily, key industry players are forecast to come across new opportunities over the coming years.

This latest study by Fact.MR offers a holistic overview of the global industry potential, demand-supply patterns, and growth and restraining factors for the forecast period of 2021 to 2031. As stated in the report, the United States, Germany, China, Japan, the United Kingdom, and a few other countries will emerge as prominent markets for sterile vials, while 20+ countries will exhibit high growth potential during the forecast period.

Historical Trends Vs. Future Outlook on Sterile Vial Sales

Sales of sterile vials have gained traction over the past decade as the requirement from the key end-use sectors such as clinical labs, compounding labs, and biopharmaceutical companies, to name a few, increased steadily. Additionally, increase in investments by manufacturers to bring in more advanced range of products has further bolstered the growth of key players during the last 5 years from 2016 to 2020.

As advancements in manufacturing sectors are taking over, manufacturers of sterile vials are optimistic to come across higher growth scope in the foreseeable future. Increase in governmental investments in the biopharmaceutical sector, steady expansion of other key end-use industries, and rising demand for COVID-19 sterile vials are expected to offer more growth opportunities for sterile vial suppliers during the forecast period of 2021 to 2031, with the market projected to expand at around 8.5% CAGR over the next ten years.

How is Demand from Clinical Labs Spearheading Growth of Sterile Vial Suppliers?

Sterile vials are widely used in clinical labs for the administration of various medications, R&D activities, and others. As demand from this sector is surging fast, suppliers of sterile vials are expected to come across ample opportunities in the foreseeable future.

According to a report titled “Clinical Laboratory Improvement Amendment (CLIA)”, published by The Centers for Medicare & Medicaid Services (CMS) on 9th March 2021, the United States clinical laboratory sector is highly potential and expected to expand significantly over the coming years. As stated in the report, in total, CLIA covers approximately 260,000 laboratory entities. This gives a glimpse of the growing opportunities for sterile vial manufactures.

What are the Key Challenges Faced by Sterile Vial Manufacturers?

There are a few restraining factors associated with sterile vials that act as challenges for suppliers and manufacturers, such as-

• High laboratory expenses during production cycle
• Additional storage, transportation, and maintenance costs
• Limitations due to the guidelines imposed by governments & non-profit organizations regarding the usage of plastics

However, with continuous efforts and investments put in R&D activities by manufacturers, the effects of these constraints are expected to get minimized in the near future.

Country-Wise Analysis

What’s Driving Sales of Sterile Vials in the United States?

The United States is huge market for sterile vials and expected to maintain its lead during the forecast period. Steadily rising demand for sterile vials for pharmaceutical applications, and rising demand for sterile vials from compounding labs, clinical labs and other key end-use sectors is boosting sales in the U.S.

According to a report published by Select USA, the U.S. biopharmaceuticals industry accounted for more than US$ 1.3 trillion in economic output, representing 4% of total U.S. output in 2015 alone. As stated in the report, this total economic impact includes US$ 558 billion in revenue from biopharmaceutical businesses and US$ 659 billion from supplier and worker spending. These statistics justify the ample of opportunities for sterile vial providers in the U.S.

What Makes Germany a Heavyweight for Sterile Vial Products?

Germany has been dominating the market in Europe since the past decade, and is likely to exhibit hegemony throughout the forecast period. Backed by advanced clinical laboratories and biopharmaceutical sector, Germany is a hotspot for key players manufacturing sterile vials.

As stated in a report published by the European Commission (EC), Germany is the leading pharmaceutical industry in the European Union (EU), and is subject to exponential growth over the coming years. As stated in the report, more than 500 pharmaceuticals companies are located in Germany, and sales are expected to surpass US$ 48 billion by 2031. No doubt that suppliers of sterile vials are eyeing Germany in order to increase their sales footprint.

Will China’s Huge Pharmaceutical Industry Drive Demand for Sterile Vials?

China has been in the limelight of Asia Pacific’s market for sterile vials since the past decade. Incorporation of cutting-edge technologies by manufacturers and surge in demand from biopharmaceutical and clinical sectors are spurring market growth in China.

As stated in a report published by Select USA, China’s pharmaceutical industry value reached almost US$ 134 billion in 2018, and grew to US$ 154 billion in 2020. According to the report, factors such as government reforms to channel patient volumes to local medical facilities, saturation of major hospital markets in tier-one cities, and others are projected to aid the growth of China’s biopharmaceutical industry over the coming years. This represents the lucrative opportunities awaiting sterile vial manufacturers in the country.

Will India Remain a Prominent Market for Sterile Vials?

Backed by growing number of clinical laboratories and biopharmaceutical & biotechnological research institutes, India is a hotspot for players in the sterile vials industry.

According to a report titled “Biotechnology Industry in India”, published by Invest India, India is among the top 12 destinations for biotechnology in the world, with nearly 3% share in the global industry. As stated in the report, by 2025, India’s biotechnology industry is expected to reach US$ 150 billion, which is bound to throw up lucrative opportunities for sterile vial manufacturers in the country.

Category-Wise Insights

Which Product is Spurring Sales of Sterile Vial Manufacturers?

Presently, sterile empty vials are leading the global market in terms of product, and are set to exhibit hegemony over the coming years. There are different types of sterile empty vials that are extensively used in various sectors, such as sterile evacuated vials, sterile nitrogen filled vials, and sterile air filled vials. As a result, demand for plastic sterile vials as well as demand for glass sterile vials is expected to rise further in the near future.

Other key segments fuelling sales in terms of product are sterile liquid-filled vials and individual sterilized components.

Why are Glass Sterile Vials Highly Preferred?

Currently, glass is the most preferred material for manufacturing sterile vials, owing to various advantages such as-

• Non-reactive
• Cost-effective
• Complies with the environmental laws and regulations
• Extensive usage

Demand for glass sterile vials for vaccines is also expected to increase. Plastic is the other key material that is aiding overall demand and sales of sterile vials.

Competitive Landscape

With the competition getting fiercer, sterile vial manufacturers are diversifying their products.

For instance,

• Dalton Pharma Services recently launched its new extensive range of Dalton Clinical Sterile Vials.
• Nipro Corporation recently launched its new eNgage Fully Customizable Vials for diverse end-use sectors.

Report Scope

Attribute	Details
Forecast Period	2021-2031
Historical Data Available for	2016-2020
Market Analysis	USD Million for Value
Key Regions Covered	North America Latin America Europe South Asia East Asia the Middle East & Africa Oceania
Key Countries Covered	US Canada Germany U.K. France Italy Spain Poland Russia China Japan South Korea India Thailand Malaysia Vietnam Indonesia Australia New Zealand GCC Countries Turkey Northern Africa South Africa
Key Segments Covered	Product Volume Material End User Region
Key Companies Profiled	Adelphi Healthcare Packaging APG Europe Bormioli Pharma S.p.a. Corning Incorporated Dalton Pharma Services DWK Life Sciences GmbH Gerresheimer AG Nipro Corporation O.Berk Company Pacific Vial Piramal Glass Schott AG SDG Pharma Shandong Pharmaceutical Glass Co. Ltd. SiO2 Materials Science Stevanato Group Thermo Fisher Scientific, Inc. West Pharmaceutical Services, Inc.
Report Coverage	Market Forecasts Brand Share Analysis Competition Intelligence DROT Analysis Market Dynamics and Challenges Strategic Growth Initiatives

Market Segmentation by Category

• Product

  • Sterile Empty Vials
    • Sterile Evacuated Vials
    • Sterile Nitrogen Filled Vials
    • Sterile Air Filled Vials
  • Sterile Liquid Filled Vials
    • Sterile Saline Filled Vials
    • Sterile Media Filled Vials
    • Sterile Water Filled Vials
  • Individual Sterilized Components

• Volume

  • <2 ml Sterile Vials
  • 2 ml to 5 ml Sterile Vials
  • 5 ml to 10 ml Sterile Vials
  • 10 ml to 20 ml Sterile Vials
  • >20 ml Sterile Vials

• Material

  • Glass Sterile Vials
  • Plastic Sterile Vials

• End User

  • Sterile Vials for Clinical Labs
  • Sterile Vials for Compounding Labs
  • Sterile Vials for Biopharmaceutical Companies
  • Sterile Vials for CMOs
  • Others

• Region

  • North America
  • Latin America
  • Europe
  • Middle East and Africa (MEA)
  • East Asia
  • South Asia
  • Oceania